DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Genesys International Corporation Limited — Allotment of Securities

NSE 6d ago·24 Aug 2026, 3:04 pm

GENESYS-RE NSE

Genesys International Corporation Limited has confirmed the allotment of 2.5 crore new shares to investors. This follows the company's decision to raise capital through a Rights Issue, allowing existing shareholders to purchase additional shares at a specific price.

This move is significant as it increases the total number of shares in circulation. For investors, this dilutes the ownership percentage of current shareholders, though the company gains fresh funds to potentially fuel its business growth and expansion plans.

Investors should monitor how the company plans to utilize these fresh funds. Future announcements regarding the use of proceeds and the company's operational performance will be key to understanding the long-term impact of this capital raise.